JPH061723A - Renal function improving medicine - Google Patents
Renal function improving medicineInfo
- Publication number
- JPH061723A JPH061723A JP4180309A JP18030992A JPH061723A JP H061723 A JPH061723 A JP H061723A JP 4180309 A JP4180309 A JP 4180309A JP 18030992 A JP18030992 A JP 18030992A JP H061723 A JPH061723 A JP H061723A
- Authority
- JP
- Japan
- Prior art keywords
- extraction
- extract
- leaves
- tea
- renal function
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、マメ科に属するアスパ
ラサス・リネアリスの含有成分を有効成分とする腎臓機
能改善治療、利尿剤に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a renal function-improving treatment and a diuretic agent containing an active ingredient of Aspalathus linealis belonging to the legume family.
【0002】[0002]
【従来の技術】従来より,乏尿性腎臓疾患に対しては、
アルダクトン(大日本製薬社)などのアルドステロン拮
抗薬、ラシックス(ヘキスト社)などのループ利尿薬、
あるいはダイアモックス(武田薬品社)などの炭酸脱水
素酵素阻害薬などの利尿剤が知られている。2. Description of the Related Art Conventionally, for oliguric kidney disease,
Aldosterone antagonists such as Aldacton (Dainippon Pharmaceutical Co., Ltd.), loop diuretics such as Lasix (Hoechst),
Alternatively, diuretics such as carbonic anhydrase inhibitors such as Diamox (Takeda Pharmaceutical Company) are known.
【0003】[0003]
【発明が解決しようとする課題】しかし、利尿剤はN
a,K輸送担体を阻止したり、炭酸脱水素酵素を阻害し
たりあるいはアルドステロンに対する拮抗作用をする人
工合成化合物を用いているために、副作用もあり一時的
な薬剤としては有効であるが、長期間使用することは不
可能である。However, the diuretic is N
It is effective as a temporary drug because it has side effects because it uses an artificial synthetic compound that blocks a, K transport carriers, inhibits carbonic anhydrase, or antagonizes aldosterone. It cannot be used for a period of time.
【0004】また、腎臓疾患は従来よりナトリウム摂取
を制限する食事療法が行なわれているが、患者の食生活
における味の変化の為に、ナトリウム摂取を制限する食
事療法では効果が薄いか長時間を要するため、十分な効
果を得るには難しい。[0004] For renal diseases, a diet therapy that restricts sodium intake has been conventionally performed. However, due to a change in taste in patients' diets, a diet therapy that restricts sodium intake is less effective or long-term. Therefore, it is difficult to obtain a sufficient effect.
【0005】本発明は、前記課題を解決し、腎臓疾患、
特に急性腎炎など乏尿性腎疾患に有効な症状の改善治療
剤を提供することを目的とする。The present invention solves the above-mentioned problems and improves kidney disease,
In particular, it is an object of the present invention to provide a therapeutic agent for improving symptoms which is effective for oliguric renal diseases such as acute nephritis.
【0006】そこで、本発明者らは、前記目的を達成す
るために鋭意研究を重ねた結果、マメ科に属するアスパ
ラサス・リネアリス抽出物が、急性腎炎などの乏尿性腎
臓疾患に対し優れた効果を有し、かつ副作用がなく安全
に各種皮膚疾患等を改善できるとの知見を得て本発明を
完成した。[0006] Therefore, as a result of intensive studies for achieving the above-mentioned object, the present inventors have found that Asparasus linealis extract belonging to the legume family was excellent against oliguric kidney diseases such as acute nephritis. The present invention has been completed based on the finding that it has effects and can safely improve various skin diseases without side effects.
【0007】本成分の有効成分は、アスパラサス・リネ
アリスの抽出液からなり、抽出法としては、アスパラサ
ス・リネアリスの葉または茎を水及び/または有機溶媒
で抽出し、該抽出液より抽出溶媒を留去する方法、また
はアスパラサス・リネアリスの葉または茎を粉砕するこ
とによって得ることができる。また、通常の日本茶、中
国茶、紅茶などの製法と同様に抽出してもよい。The active ingredient of this component consists of an extract of Aspalathus linealis. As the extraction method, leaves or stems of Aspalathus linealis are extracted with water and / or an organic solvent, and the extraction solvent is extracted from the extract. Can be obtained by distilling off or by crushing leaves or stems of Aspalathus linealis. In addition, it may be extracted in the same manner as in the production method of ordinary Japanese tea, Chinese tea, black tea and the like.
【0008】水で抽出する場合には、アスパラサス・リ
ネアリスの50〜1000倍の水を加え、90〜100
度で5〜30分程度抽出するのが好ましい。また、通常
の茶と同様にするときは、アスパラサス・リネアリスの
乾燥葉の50〜1000倍の水を加え、90〜100度
で5〜30分間程度沸騰させ抽出液を得る。In the case of extraction with water, 50 to 1000 times as much water as Aspalathus linealis is added, and 90 to 100 is added.
It is preferable to extract for about 5 to 30 minutes. Moreover, when making it the same as normal tea, 50 to 1000 times as much water as dry leaves of Aspalathus linealis is added, and the extract is boiled at 90 to 100 degrees for about 5 to 30 minutes to obtain an extract.
【0009】有機溶媒の具体例としては、メタノール、
エタノール、アセトン等が挙げられ、抽出にあたっては
温時抽出等慣用手段を用いることができる。また、抽出
液の分離も、デカンテーションや遠心分離等の慣用手段
を用いることができる。Specific examples of the organic solvent include methanol,
Ethanol, acetone and the like can be mentioned, and conventional means such as warm extraction can be used for extraction. Further, for the separation of the extract, conventional means such as decantation or centrifugation can be used.
【0010】抽出溶媒の留去も凍結乾燥等の慣用手段を
用いることができる。また、アスパラサス・リネアリス
そのものを粉砕し、微小化・粉末化して用いることもで
きる。A conventional means such as freeze-drying can be used for distilling off the extraction solvent. In addition, Aspalathus linealis itself can be crushed, and can be used after being miniaturized and powdered.
【0011】本組成物は、有効成分を生理学的に許容さ
れうる担体、賦形剤、結合剤、希釈剤と混合し、たとえ
ば顆粒剤、粉剤、硬カプセル剤、軟カプセル剤、塗布
剤、シロップ、坐剤、注射剤として経口または非経口的
に、または、混合してそのまま溶液、粉末顆粒、錠剤、
乳剤、ゼリー状など任意の形態で単独投与、濃縮液を利
用、または他の飲食物に混合して飲食することもでき
る。The composition is prepared by mixing the active ingredient with physiologically acceptable carriers, excipients, binders and diluents, for example granules, powders, hard capsules, soft capsules, coatings and syrups. , Suppositories, orally or parenterally as injections, or as a mixture as it is, solutions, powder granules, tablets,
It can be administered alone in any form such as an emulsion or jelly, can be used as a concentrated solution, or can be mixed with other foods and drinks.
【0012】投与量は、対象となる疾患の種類、程度に
より異なるが、飲料としてヒトが常用する場合には、1
〜5g乾燥葉/1溶液を100ml〜2000ml/日
飲食するのが好ましい。ペットなどの動物に与える場合
には2ml/kg体重〜30ml/kg体重与えるのが
好ましい。また、凍結乾燥顆粒粉末のときは、それぞれ
1g〜10g/日与えるのが好ましい。The dose varies depending on the kind and degree of the target disease, but in the case where humans regularly use it as a drink, the dose is 1
It is preferable to eat and drink ~ 5 g dry leaf / 1 solution at 100 ml-2000 ml / day. When given to animals such as pets, it is preferable to give 2 ml / kg body weight to 30 ml / kg body weight. In the case of freeze-dried granule powder, it is preferable to give 1 g to 10 g / day, respectively.
【0013】アスパラサス・リネアリスは、ラットに対
する急性毒性試験で死亡例は皆無であり、生化学血液検
査および病理組織学的検査においても異常が認められな
かった。[0013] Aspalathus linealis showed no death in an acute toxicity test in rats, and no abnormality was observed in biochemical blood tests and histopathological tests.
【0014】[0014]
【効果】本発明は、ヒトを含む哺乳動物の腎臓疾患、特
に乏尿性腎臓疾患を飲食等により副作用無く、迅速に改
善す治療ることができる。[Effect] The present invention can treat renal diseases of mammals including humans, in particular, oliguric renal diseases, which can be rapidly improved by eating or drinking without side effects.
【0015】[0015]
製造例 採取したアスパラサス・リネアリスの葉(茎つき)を、
5mm長に切断後、ローリング、酵素醗酵、天日乾燥の
工程を経て乾燥葉とする。乾燥葉4gを水1.5リット
ルで15分間沸騰させ抽出液を得た。Production example Collected Aspalathus linealis leaves (with stem)
After cutting to a length of 5 mm, dried leaves are subjected to the steps of rolling, enzyme fermentation, and sun drying. 4 g of dried leaves were boiled with 1.5 liters of water for 15 minutes to obtain an extract.
【0016】実施例 製造例で得たアスパラサス・リネアリス抽出液を腎機能
が低下し顔面に浮腫のあるパネラー5名に一日コップ1
〜5杯飲ませ、腎機能の改善を調べた。その結果、4名
において飲み始めてすぐに利尿作用により尿量も多くな
り、1〜2週間で顔面の浮腫もあらわれなくなり、疲れ
なくなった。Example 1 cup of the Aspalathus linealis extract obtained in the production example per day for 5 panelists with reduced renal function and edema on the face
~ 5 cups were given and examined for improvement in renal function. As a result, in 4 persons, the amount of urine increased due to a diuretic effect immediately after starting drinking, and facial edema did not appear in 1 to 2 weeks, and the body became tired.
Claims (2)
成分とする腎臓機能改善治療剤。1. A therapeutic agent for improving renal function, comprising an Aspalathus linealis extract as an active ingredient.
成分とする利尿剤。2. A diuretic containing an Aspalathus linealis extract as an active ingredient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4180309A JPH061723A (en) | 1992-06-15 | 1992-06-15 | Renal function improving medicine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4180309A JPH061723A (en) | 1992-06-15 | 1992-06-15 | Renal function improving medicine |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH061723A true JPH061723A (en) | 1994-01-11 |
Family
ID=16080963
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4180309A Pending JPH061723A (en) | 1992-06-15 | 1992-06-15 | Renal function improving medicine |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH061723A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003299456A (en) * | 2002-04-09 | 2003-10-21 | Masayoshi Iwahara | Epidermal powder of asparasus linearis or asparasus cederbergensis and method for producing the same |
CN104189790A (en) * | 2014-09-30 | 2014-12-10 | 河南亚卫动物药业有限公司 | Traditional Chinese medicine composition for treating cow conception edema and preparation method thereof |
CN104225027A (en) * | 2014-09-30 | 2014-12-24 | 三穗县耿德发诊所 | Medicament for treating swelling and preparation method of medicament |
-
1992
- 1992-06-15 JP JP4180309A patent/JPH061723A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003299456A (en) * | 2002-04-09 | 2003-10-21 | Masayoshi Iwahara | Epidermal powder of asparasus linearis or asparasus cederbergensis and method for producing the same |
CN104189790A (en) * | 2014-09-30 | 2014-12-10 | 河南亚卫动物药业有限公司 | Traditional Chinese medicine composition for treating cow conception edema and preparation method thereof |
CN104225027A (en) * | 2014-09-30 | 2014-12-24 | 三穗县耿德发诊所 | Medicament for treating swelling and preparation method of medicament |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5932624A (en) | Vitamin supplement composition | |
KR101687982B1 (en) | Composition for improving sexual functionality having effects of increasing of the number of sperm and protection of environmental hormone and manufacturing method thereof | |
CA2871478C (en) | Pleuropterus multiflorus extract and dipsacus asperoides extract for stimulating the secretion of insulin-like growth factor and promoting bone structure growth, and method for preparing same | |
WO2007007993A1 (en) | Pharmaceutical composition for the prevention and treatment of liver disease comprising a lonicera caerulea l. var. edulis extract | |
US6984405B1 (en) | Compositions for inducing secretion of insulin-like growth factor-1 | |
JPH05246866A (en) | Agent for stimulating cerebral metabolism and for improving cerebral function | |
KR100678519B1 (en) | A composition comprising the extract of Semisulospira libertine Sulfur Fed Duck Ulmus devidiana Pine Pollen Powder Acer tegmentosum Maxim. Bamboo Salt Artemisia capillaries Platycodon Grandiflorum Rhynchosiavolubilis for the prevention and treatment of fatty liver | |
EP1583547B1 (en) | Anti-obesity ingredients from medicinal plants and their composition | |
KR20160042521A (en) | Composition for Promoting Osteogenesis and Composition for Preventing or Treating Hyperlipidemia | |
JP3502072B2 (en) | Health food composition for protecting liver (Healthy food composition for protecting hepatic) | |
JPH06263648A (en) | Promoter for lowering alcohol in body and its metabolite and refrigerant in mouth | |
JPH061723A (en) | Renal function improving medicine | |
KR100376305B1 (en) | Healthy food composition for protecting hepatic | |
JPH0840923A (en) | Nutrient-supplying agent | |
KR20100132101A (en) | Compositions for preventing and treating allergy comprising of fruits of prunus davidiana fr | |
RU2332866C2 (en) | Dietary supplement "perstevit" | |
JPH01299224A (en) | Promoter of cholesterol excretion, use and mixture thereof | |
JP4534003B2 (en) | Health food with antiallergic action | |
JP3167777B2 (en) | Antiviral, antibacterial and bactericide | |
JP2724524B2 (en) | Constipation improvement / treatment agent | |
CN101143203A (en) | Compound oral liquid with liver-protecting and stomach-nourishing function | |
US20040146468A1 (en) | Oral compositon comprising an extract from the bark of albizzia myrioplylla | |
JPH01304861A (en) | Production of dried powder of earthworm | |
KR102281950B1 (en) | Composition for reducing toxicity containing corn silk extract | |
JPH069357A (en) | Agent for removing body smell and bad smell of excreta |